PFM
Privium Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,716
| Closed | -$1.54M | – | 57 |
|
|
2025
Q1 | $1.54M | Buy |
+5,716
| New | +$1.54M | 0.4% | 27 |
|
|
2024
Q3 | – | Sell |
-19,393
| Closed | -$4.8M | – | 84 |
|
|
2024
Q2 | $4.8M | Sell |
19,393
-1,500
| -7% | -$371K | 1.22% | 24 |
|
|
2024
Q1 | $3.12M | Sell |
20,893
-800
| -4% | -$120K | 0.83% | 29 |
|
|
2023
Q4 | $4.23M | Buy |
21,693
+1,670
| +8% | +$326K | 1.18% | 25 |
|
|
2023
Q3 | $3.55M | Buy |
+20,023
| New | +$3.55M | 1.05% | 27 |
|
|
2022
Q4 | – | Sell |
-2,100
| Closed | -$440K | – | 153 |
|
|
2022
Q3 | $440K | Sell |
2,100
-8,400
| -80% | -$1.76M | 0.16% | 63 |
|
|
2022
Q2 | $1.53M | Buy |
10,500
+5,000
| +91% | +$729K | 0.51% | 35 |
|
|
2022
Q1 | $898K | Buy |
5,500
+3,100
| +129% | +$506K | 0.2% | 63 |
|
|
2021
Q4 | $410K | Buy |
+2,400
| New | +$410K | 0.08% | 78 |
|